No Picture
Boston Cambridge Biotech Trending News

Akebia Therapeutics Regaining Rights to Vadadustat in the United States, Europe, China and Access Consortium Countries upon Termination of Collaboration and License Agreements with Otsuka

Companies finalize termination with an agreed-upon settlement fee of $55M to be paid to Akebia Akebia to assume responsibility for regulatory review processes previously led by Otsuka CAMBRIDGE, Mass., June 30, 2022 /PRNewswire/ — Akebia […]

No Picture
DC Maryland Virginia Biotech Trending News

Supreme Court Ruling Supports Americans’ Access to Energy, States Doctors for Disaster Preparedness (DDP)

TUCSON, Ariz., June 30, 2022 /PRNewswire/ — In its 6-to-3 opinion in West Virginia v. EPA, the U.S. Supreme Court reined in the U.S. Environmental Protection Agency’s attempt to limit carbon dioxide emissions to a […]

No Picture
Boston Cambridge Biotech Trending News

ROME Therapeutics Announces Publication of First Crystal Structure of a Human Endogenous Reverse Transcriptase in PNAS

CAMBRIDGE, Mass.–(BUSINESS WIRE)–ROME Therapeutics announced a publication in PNAS which describes the first X-ray crystallography structure of an endogenous reverse transcriptase. Click here to view original post